The study of the treatment efficacy in metastatic castration-resistant prostate cancer of low dose abiraterone with food.

Kanta Makphanchareonkit,Thitiya Sirisinha Dejthevaporn,Dittapol Muntham,Phichai Chansriwong

The study of the treatment efficacy in metastatic castration-resistant prostate cancer of low dose abiraterone with food.

2020

Kanta Makphanchareonkit
Thitiya Sirisinha Dejthevaporn
Dittapol Muntham
Phichai Chansriwong

e17571Background: Abiraterone acetate and prednisolone (AAP) + ADT has been approved for treatment metastatic castration-resistant prostate cancer (CRPC) in the standard dose 1,000 mg with fasting ...

Keywords:

low dose
Abiraterone
Oncology
Internal medicine
Pathology
Prostate cancer
castration resistant
Medicine
treatment efficacy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations